Pancreatic Cancer News and Research

RSS
Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.
Canadian and Israeli researchers meet to discuss underlying mechanisms that drive pancreatic cancer

Canadian and Israeli researchers meet to discuss underlying mechanisms that drive pancreatic cancer

New open access journal to deliver case reports on all aspects of pancreatic cancer

New open access journal to deliver case reports on all aspects of pancreatic cancer

Study: Nut consumption associated with decreased risk of some types of cancer, but not type 2 diabetes

Study: Nut consumption associated with decreased risk of some types of cancer, but not type 2 diabetes

Glucose-control drug sitagliptin does not raise risk of cardiovascular events

Glucose-control drug sitagliptin does not raise risk of cardiovascular events

Sanofi announces results from Phase IIIb ELIXA study of Lyxumia in adults with diabetes and high CV risk

Sanofi announces results from Phase IIIb ELIXA study of Lyxumia in adults with diabetes and high CV risk

AbbVie selects Halozyme's ENHANZE platform to augment their development pipeline

AbbVie selects Halozyme's ENHANZE platform to augment their development pipeline

El Camino Hospital enrolls first patient in safety study using RenovoCath

El Camino Hospital enrolls first patient in safety study using RenovoCath

Experimental drug and common antibiotic combination holds promise for pancreatic cancer treatment

Experimental drug and common antibiotic combination holds promise for pancreatic cancer treatment

NCCN to host policy summit on emerging issues in tissue allocation

NCCN to host policy summit on emerging issues in tissue allocation

PanCuRx initiative to reduce pancreatic cancer fatality rate receives $4.6 million investment from OICR

PanCuRx initiative to reduce pancreatic cancer fatality rate receives $4.6 million investment from OICR

Halozyme announces positive Phase 2 results of PEGPH20 drug for treating metastatic pancreatic cancer patients

Halozyme announces positive Phase 2 results of PEGPH20 drug for treating metastatic pancreatic cancer patients

PharmaEngine files NDA with Taiwan FDA for MM-398 to treat post-gemcitabine metastatic pancreatic cancer

PharmaEngine files NDA with Taiwan FDA for MM-398 to treat post-gemcitabine metastatic pancreatic cancer

ASCO 2015: UH Seidman Cancer Center researchers present data from several new studies

ASCO 2015: UH Seidman Cancer Center researchers present data from several new studies

Study findings underscore importance of PD-1/PD-L1 expression in oncogenic signaling pathways

Study findings underscore importance of PD-1/PD-L1 expression in oncogenic signaling pathways

Novartis to highlight strength of its expanded oncology portfolio at ASCO 2015

Novartis to highlight strength of its expanded oncology portfolio at ASCO 2015

Mistakes in mismatch repair genes may accurately predict response to certain immunotherapy drugs

Mistakes in mismatch repair genes may accurately predict response to certain immunotherapy drugs

Ventana, Halozyme partner to develop companion diagnostic assay for cancer treatment

Ventana, Halozyme partner to develop companion diagnostic assay for cancer treatment

Myriad Genetics announces new clinical studies on myChoice HRD companion diagnostic test at ASCO 2015

Myriad Genetics announces new clinical studies on myChoice HRD companion diagnostic test at ASCO 2015

Inhibitors BGB324 and BGB10C9 show promise in multiple murine models of pancreatic cancer

Inhibitors BGB324 and BGB10C9 show promise in multiple murine models of pancreatic cancer

TGen professor to receive top award from Arizona Medical Association

TGen professor to receive top award from Arizona Medical Association

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.